EFSPI International Events

Joint EFSPI/BBS Meeting on Adaptive Designs in Drug Development
Basel , 15th June 2007

On June 15th, 2007, EFSPI and BBS hold a Scientific One-day Meeting on Adaptive Designs in Drug Development

Opinion leaders from industry, academia and regulatory shared their views on Flexible/Adaptive Designs, via presentations and discussion.
Members of the audience were able to question the opinion leaders during panel discussion. This controversial subject generated an interesting debate.

Slides presented during the meeting are available below:

1 - Andy Grieve (King's College, London) Adaptive Designs : An Overview Download pdf file

2 - Werner Brannath (Medical University of Vienna) : Estimation in Flexible Adaptive Design Download pdf file

3 - Alun Bedding (Glaxo SmithKline) : Learning as we go: the use of Bayesian Methodology for Adaptive Designs Download pdf file

4 – Gernot Wassmer (Köln University) : Adaptive Treatment Selection with Survival Endpoints Download pdf file

5 – Fiona Guillard (Glaxo SmithKline) : Case study for a continually adapting design Download pdf file

6 – Mike K Smith (PGRD, Sandwich, UK) : Case studies of Bayesian adaptive designs using various amounts of prior information Download pdf file

7 - David Lawrence (Novartis) : Phase II/III Adaptive Design with Treatment Selection: A case study Download pdf file

8 – Rob Hemmings (MHRA, UK) : Adaptive Designs - Latest thinking from this regulator! Download pdf file